161 related articles for article (PubMed ID: 8085558)
1. Flow-cytometric analysis of nuclear DNA content in endometrial adenocarcinoma. Atypical mitoses are associated with DNA aneuploidy.
Genest DR; Sheets E; Lage JM
Am J Clin Pathol; 1994 Sep; 102(3):341-8. PubMed ID: 8085558
[TBL] [Abstract][Full Text] [Related]
2. Role of DNA ploidy analysis in endometrial adenocarcinoma.
Jhala DN; Atkinson BF; Balsara GR; Hernandez E; Jhala NC
Ann Diagn Pathol; 2001 Oct; 5(5):267-73. PubMed ID: 11598854
[TBL] [Abstract][Full Text] [Related]
3. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
[TBL] [Abstract][Full Text] [Related]
4. Image cytometry DNA ploidy correlates with histological subtypes in endometrial carcinomas.
Pradhan M; Abeler VM; Danielsen HE; Tropé CG; Risberg BA
Mod Pathol; 2006 Sep; 19(9):1227-35. PubMed ID: 16729014
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of flow cytometric deoxyribonucleic acid index in endometrial carcinoma: comparison with other clinical-pathologic parameters.
Susini T; Rapi S; Savino L; Boddi V; Berti P; Massi G
Am J Obstet Gynecol; 1994 Feb; 170(2):527-34. PubMed ID: 8116708
[TBL] [Abstract][Full Text] [Related]
6. DNA content is an independent prognostic indicator in endometrial adenocarcinoma. A Gynecologic Oncology Group study.
Zaino RJ; Davis AT; Ohlsson-Wilhelm BM; Brunetto VL
Int J Gynecol Pathol; 1998 Oct; 17(4):312-9. PubMed ID: 9785131
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of cell kinetics in endometrial adenocarcinoma.
Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
[TBL] [Abstract][Full Text] [Related]
8. DNA ploidy status: its impact on early-stage endometrial adenocarcinoma.
Goodman A; Bell DA; Rice LW
Gynecol Oncol; 1993 Dec; 51(3):355-61. PubMed ID: 8112645
[TBL] [Abstract][Full Text] [Related]
9. Prospective analysis of DNA ploidy, proliferative index and epidermal growth factor receptor as prognostic factors for pretreated uterine cancer.
Nagai N; Oshita T; Fujii T; Kioka H; Katsube Y; Ohama K
Oncol Rep; 2000; 7(3):551-9. PubMed ID: 10767367
[TBL] [Abstract][Full Text] [Related]
10. Tumor cell cycle in patients with stage I endometrial carcinoma.
Vecek N; Nola M; Marusić M; Babić D; Uzarević B; Sabioncello A; Petrovecki M; Ljubić-Racunica N; Marinović T
Gynecol Oncol; 1994 Apr; 53(1):38-43. PubMed ID: 8175020
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
Konski AA; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Mah J; Eggleston W
Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic evaluation of endometrial carcinoma by DNA content and histologic factors].
Shimizu K
Nihon Sanka Fujinka Gakkai Zasshi; 1995 Apr; 47(4):413-8. PubMed ID: 7730696
[TBL] [Abstract][Full Text] [Related]
13. DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival.
Enker WE; Kimmel M; Cibas ES; Cranor ML; Melamed MR
J Natl Cancer Inst; 1991 May; 83(10):701-7. PubMed ID: 2023271
[TBL] [Abstract][Full Text] [Related]
14. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
Xue F; Jiao S; Zhao F
Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
[TBL] [Abstract][Full Text] [Related]
15. Flow cytometric analysis of endometrial stromal sarcoma.
Hitchcock CL; Norris HJ
Am J Clin Pathol; 1992 Feb; 97(2):267-71. PubMed ID: 1546695
[TBL] [Abstract][Full Text] [Related]
16. Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas.
Harlow SP; Eriksen BL; Poggensee L; Chmiel JS; Scarpelli DG; Murad T; Bauer KD
Cancer Res; 1991 May; 51(9):2403-9. PubMed ID: 2015602
[TBL] [Abstract][Full Text] [Related]
17. Endometrial carcinomas--flow cytometric DNA content and S-phase values.
Jacobsen M; Jakobsen A; Nedergaard L; Andersen JE; Nielsen K
Pathol Res Pract; 1997; 193(4):283-90. PubMed ID: 9258954
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis of nuclear DNA content in ovarian tumors. Association of ploidy with tumor type, histologic grade, and clinical stage.
Lage JM; Weinberg DS; Huettner PC; Mark SD
Cancer; 1992 Jun; 69(11):2668-75. PubMed ID: 1571896
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of prognostic factors following flow-cytometric DNA analysis after cytokeratin labelling: II. Cervical and endometrial cancer.
Wimberger P; Hillemanns P; Kapsner T; Hepp H; Kimmig R
Anal Cell Pathol; 2002; 24(4-5):147-58. PubMed ID: 12590151
[TBL] [Abstract][Full Text] [Related]
20. DNA aneuploidy is associated with increased mortality for stage I endometrial cancer.
Terada K; Mattson D; Goo D; Shimizu D
Gynecol Oncol; 2004 Dec; 95(3):483-7. PubMed ID: 15581950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
